Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02326675 · ClinicalTrials.gov registry record · NA
Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02326675 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 29 participants.
The verdict
NCT02326675, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Oral mucositis is a common complication of cancer therapy. Mucositis results from damage to the mucosal epithelium after delivery of chemotherapy or radiation treatments designed to treat the cancer. A number of treatment factors have been shown to influence the incidence and severity of mucositis, including chemotherapy type and dosage. High-dose chemotherapy before stem cell transplantation can cause severe oral mucositis and is often the side effect that patients find the most difficult to endure. Cryotherapy, keeping ice chips in the mouth during chemotherapy infusion, has been shown to prevent or alleviate mucositis caused by high-dose melphalan alone or given in combinations used in pre-transplant conditioning. One other drug notorious for causing severe mucositis is etoposide (VP-16). The specific aims of the study are: 1) to assess tolerability of cryotherapy given during chemotherapy administration; 2) to determine the efficacy of cryotherapy in reducing etoposide-induced mucositis.
Interventions
- OTHER Ice
- OTHER Normal Saline Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02326675
The ClinicalTrials.gov registry entry for NCT02326675 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ice is the first listed.
NCT02326675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02326675 about?
NCT02326675 is a clinical study titled "Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant". Oral mucositis is a common complication of cancer therapy. Mucositis results from damage to the mucosal epithelium after delivery of chemotherapy or radiation treatments designed to treat the cancer. A number of treatment factors have been shown to influence the incidence and severity of mucositis, ...
What is the current status of trial NCT02326675?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2015-03. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02326675?
The interventions under investigation include: Ice (OTHER), Normal Saline Solution (OTHER).
Who is sponsoring clinical trial NCT02326675?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.